<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04474041</url>
  </required_header>
  <id_info>
    <org_study_id>EYEQUE - 006</org_study_id>
    <nct_id>NCT04474041</nct_id>
  </id_info>
  <brief_title>Study to Evaluate Visual Acuity Measured With the EyeQue Insight Versus a Standard Eyechart.</brief_title>
  <official_title>A Clinical Study to Evaluate Visual Acuity Measured With the EyeQue Insight Versus an Eyechart in a Healthcare Office Environment.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>EyeQue Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eye Boutique Optometry</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>EyeQue Corp.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open label exploratory study of the EyeQue Insight in healthy volunteers &gt;=7 years of age.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to determine whether the EyeQue Insight (ETDRS visual&#xD;
      acuity test) yields results similar to the standard ETDRS eyechart in the office.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 3, 2020</start_date>
  <completion_date type="Actual">December 24, 2020</completion_date>
  <primary_completion_date type="Actual">December 24, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acuity Visit 1</measure>
    <time_frame>Visit 1: Day 0</time_frame>
    <description>Variance of best-corrected (BCVA) monocular VA of each participant's OD and OS measured on the ETDRS chart and the ETDRS test of the EyeQue Insight at Visit 1.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acuity Visit 1 and 2</measure>
    <time_frame>Visit 1 (Day 0) and Visit 2 (Day 7)</time_frame>
    <description>Variance of the best-corrected VA (BCVA) of each participant's OD, OS, and OU measured on the ETDRS chart and the ETDRS test of the EyeQue Insight at Visit 1 and Visit 2.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">89</enrollment>
  <condition>Visual Acuity</condition>
  <arm_group>
    <arm_group_label>Visual Acuity with a Hand-held Device Supported by Mobile App.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Insight will be compared to a standard ETDRS eyechart</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EyeQue Insight</intervention_name>
    <description>The Insight will be used to measure visual acuity and compared with a standard ETDRS eye chart.</description>
    <arm_group_label>Visual Acuity with a Hand-held Device Supported by Mobile App.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or Female&#xD;
&#xD;
          2. Ages =&gt;7 y.o.&#xD;
&#xD;
          3. Subjects that are minors (&lt;18 years old) must have a parent or legal guardian.&#xD;
&#xD;
          4. Binocular vision&#xD;
&#xD;
          5. Willing and able to give informed consent and follow all study procedures and&#xD;
             requirements&#xD;
&#xD;
          6. Fluent in English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Has been diagnosed within 4 weeks, or currently has signs or symptoms, of COVID-19.&#xD;
&#xD;
          2. Has traveled outside the country within the last 4 weeks&#xD;
&#xD;
          3. Medications:&#xD;
&#xD;
             a. Taking medications that may affect ability to follow instructions.&#xD;
&#xD;
          4. Eye Disease:&#xD;
&#xD;
             a. Subjects with eye disease deemed by the Investigator to be inappropriate for the&#xD;
             study such as an active eye infection.&#xD;
&#xD;
          5. Subjects that:&#xD;
&#xD;
               1. Lack physical dexterity to properly operate the EyeQue App on the smartphone&#xD;
&#xD;
               2. Lack the ability to follow instruction&#xD;
&#xD;
               3. Lack binocular vision&#xD;
&#xD;
               4. Lack the ability to maintain both eyes open&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>EyeQue</name>
      <address>
        <city>Newark</city>
        <state>California</state>
        <zip>94560</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>July 1, 2020</study_first_submitted>
  <study_first_submitted_qc>July 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 16, 2020</study_first_posted>
  <last_update_submitted>March 23, 2021</last_update_submitted>
  <last_update_submitted_qc>March 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>visual acuity</keyword>
  <keyword>screening</keyword>
  <keyword>vision</keyword>
  <keyword>eye care</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

